Improving metabolic health may lower risk for colorectal neoplasia recurrence in MASLD

Patients with metabolic dysfunction-associated steatotic liver disease who improved their metabolic health after polypectomy significantly lowered their risk for metachronous advanced colorectal neoplasia, study results showed.Findings also suggested that those with the highest metabolic burden or any advanced colorectal neoplasia at baseline benefited most from lifestyle interventions to reduce